Norgesic: Difference between revisions
CSV import |
CSV import Tag: Reverted |
||
| Line 42: | Line 42: | ||
{{dictionary-stub1}} | {{dictionary-stub1}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Revision as of 20:21, 17 March 2025
| Norgesic | |
|---|---|
| [[File:|frameless|220px|alt=|]] | |
| INN | |
| Drug class | |
| Routes of administration | Oral |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 509146-28-5 |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Norgesic is the brand name of a muscle relaxant produced by Medicis Pharmaceutical (currently Valeant Pharmaceuticals). The generic is a combination of 385 mg of paracetamol, 25 mg of orphenadrine citrate<ref>
Norgesic(link). {{{website}}}.
</ref> and 30 mg of caffeine.<ref>,
Back Pain: A Guide for the Primary Care Physician, Versa Press, 2005, ISBN 1-930513-59-3,</ref>
It was discontinued in the United States by the Food and Drug Administration in October 2015<ref>
Determination That TENSILON and TENSILON Preservative Free (Edrophonium Chloride) Injectable and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness(link). {{{website}}}. Food and Drug Administration, Federal Register Volume 80, # 210. 2015-10-30.
Accessed 2017-08-26.
</ref> but is still available in Scandinavia, Austria, Greece, Thailand, Australia and Hong Kong.
(September 2016)
References
<references group="" responsive="1"></references>

